The role of platelets in venous thrombosis: A patient with Glanzmann's thrombasthenia and a factor V Leiden mutation suffering from deep venous thrombosis

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 2, 2003, Pages 394-395

  Ten Cate, H ^a   Brandjes, D P M ^a   Smits, P H M ^a   Van Mourik, J A ^b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b Sanquin ^*  (Netherlands)

Author keywords

Factor V Leiden; Glanzmann's disease; Platelets; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN;

BLOOD; CASE REPORT; GENETICS; GLANZMANN DISEASE; HUMAN; IMMOBILIZATION; LETTER; MALE; MIDDLE AGED; PHYSIOLOGY; POINT MUTATION; THROMBOCYTE; VEIN THROMBOSIS;

BLOOD PLATELETS; FACTOR V; HUMANS; IMMOBILIZATION; MALE; MIDDLE AGED; POINT MUTATION; THROMBASTHENIA; VENOUS THROMBOSIS;

EID: 0141561924     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00041.x     Document Type: Letter

References (11)

1. Imperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994; 271: 1780-5.
2. Westrich GH, Haas SB, Mosca P, Peterson M. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty. J Bone Joint Surg 2000; 82: 795-80.
3. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355: 1295-302.
4. George JN, Caen J-P, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990; 75: 1383.
5. Gruel Y, Pacouret G, Bellucci S, Caen J. Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin. Blood 1997; 90: 888-90.
6. Reyers I, de Gaetano G, Donati MB. Venostasis-induced thrombosis in rats is not influenced by circulating platelet or leukocyte number. Agents Actions 1989; 28: 137-41.
7. Millet J, Theveniaux J, Pascal M. A new experimental model of venous thrombosis in rats involving partial stasis and slight endothelium alterations. Thromb Res 1987; 45: 123-33.
8. Herault et al. Herbert JM, Bernat A, Maffrand JP. Importance of platelets in experimental venous thrombosis in the rat. Blood 1992; 80: 2281-6.
9. Yamamoto H, Vreys I, Stassen JM, Yoshimoto R, Vermylen J, Hoylaerts MF. Antagonism of vWF inhibits both injury induced arterial and venous thrombosis in the hamster. Thromb Haemost 1998; 79: 202-10.
10. Stockmans F, Deckmyn H, Gruwez J, Vermylen J, Acland R. Continuous quantitative monitoring of mural, platelet-dependent, thrombus kinetics in the crushed rat femoral vein. Thrombos Haemost 1991; 65: 425-31.
11. ten Cate H, Aird WC. Lessons from venous thrombosis and disseminated intravascular coagulation: a synthesis of pathophysiological mechanisms of prothrombotic states. In: ten Cate H, Levi M, eds. Disseminated Intravascular Coagulation: Molecular Mechanisms. Landes Publishers, George town, TX, USA. 2003: in press.